Adults
Conditions
Interventions
Trial L (test meal at lunch), 3 times >
Trial D (test meal at dinner), 3 times
Trial D (test meal at dinner), 3 times >
Trial L (test meal at lunch), 3 times
Sponsors
Otsuka Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Subjects who are voluntarily giving written informed consent. 2) Adult males aged between 20 and 65. 3) Subjects who can take meals, take urine samples and stay quiet and rest on the schedule indicated by investigators.
Exclusion criteria
Exclusion criteria: 1) Subjects whose clinical inspection results are outside of the reference range and who are estimated inappropriate to this study by principal investigator. 2) Subjects who have or had disorder in digestive, circulatory or endocrine system and who are estimated inappropriate to this study by principal investigator. 3) Subjects who have food allergy. 4) Subjects who are excess of daily salt intake. 5) Subjects who are estimated inappropriate to participate to this study by principal investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary electrolytes excretion and urine volume | — |
Countries
Japan
Contacts
Public ContactShintaro Ono
Otsuka Pharmaceutical Co., Ltd. Saga Nutraceuticals Research Institute
Outcome results
None listed